SCHEMBL8060583

SCHEMBL8060583

O=C(/C=C/c1cccc(Cl)c1)Nc1cccc(C(=O)O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.73
MMP1 P03956 5/20 0.73
MMP2 P08253 5/20 0.73
MMP9 P14780 5/20 0.73
MAOA P21397 4/20 0.73
EGFR P00533 2/20 0.73
LTB4R Q15722 1/20 0.67
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
NPC1 O15118 3/20 0.66
RAB9A P51151 3/20 0.66
MAPT P10636 2/20 0.66
LMNA P02545 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
KDM4E B2RXH2 1/20 0.66
ALDH1A1 P00352 1/20 0.66
HTT P42858 1/20 0.66
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2D6 P10635 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8060586 1.00 MAOB (0.73) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8048920 0.88 LTB4R (0.76) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8048917 0.88 LTB4R (0.76) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8049033 0.88 LTB4R (0.84) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8049032 0.88 LTB4R (0.84) MAOBMMP1MMP2MMP9MAOA
3-Chloro-Cinnamanilide SCHEMBL1538355 0.88 MMP1 (0.83) MAOBMMP1MMP2MMP9MAOA
3-Chloro-Cinnamanilide SCHEMBL1538356 0.88 MMP1 (0.83) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8059959 0.86 LTB4R (0.69) MAOBMMP1MMP2MMP9MAOA
SCHEMBL8059954 0.86 LTB4R (0.69) MAOBMMP1MMP2MMP9MAOA
SCHEMBL6013373 0.85 MMP1 (0.79) MAOBMMP1MMP2MMP9LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed